Hypothesis and Theory
Published on 18 Sep 2024
DeltaRex-G, tumor targeted retrovector encoding a CCNG1 inhibitor, for CAR-T cell therapy induced cytokine release syndrome
in Molecular Medicine and Cancer Treatment
- 618 views
Hypothesis and Theory
Published on 18 Sep 2024
in Molecular Medicine and Cancer Treatment
Editorial
Published on 27 Feb 2024
in Molecular Medicine and Cancer Treatment
Original Research
Published on 24 Jul 2023
in Molecular Medicine and Cancer Treatment
Editorial
Published on 27 Jun 2023
in Molecular Medicine and Cancer Treatment
Mini Review
Published on 06 Jun 2023
in Molecular Medicine and Cancer Treatment
Original Research
Published on 18 May 2023
in Molecular Medicine and Cancer Treatment
Original Research
Published on 20 Apr 2023
in Molecular Medicine and Cancer Treatment
Perspective
Published on 23 Mar 2023
in Molecular Medicine and Cancer Treatment
Review
Published on 28 Feb 2023
in Molecular Medicine and Cancer Treatment
Original Research
Published on 22 Feb 2023
in Molecular Medicine and Cancer Treatment
Original Research
Published on 16 Dec 2022
in Molecular Medicine and Cancer Treatment
Review
Published on 13 Dec 2022
in Molecular Medicine and Cancer Treatment
Original Research
Published on 13 Dec 2022
in Molecular Medicine and Cancer Treatment
Review
Published on 16 Nov 2022
in Molecular Medicine and Cancer Treatment
Original Research
Published on 11 Oct 2022
in Molecular Medicine and Cancer Treatment
Mini Review
Published on 10 Oct 2022
in Molecular Medicine and Cancer Treatment